TL;DR

Key Facts

What Are They?

Odontogenic tumours are a heterogeneous group of neoplasms and hamartomas that arise from the various cellular components of the tooth-forming apparatus — the dental epithelium (enamel organ, dental lamina, reduced enamel epithelium, epithelial rests of Malassez) and the associated dental ectomesenchyme (dental papilla, dental follicle, periodontal ligament). Because the developing tooth involves complex epithelial-mesenchymal interactions, odontogenic tumours may contain epithelial elements alone, mesenchymal elements alone, or a combination of both.

The jaw is a unique anatomical site in that it is the only location in the body where epithelium (odontogenic epithelium) is normally found within bone. This explains why the jaws are the exclusive site of origin for this entire class of neoplasm. Most odontogenic tumours are confined to the jaw bones, though a small number can arise in the overlying soft tissue (peripheral variants).

The biology of odontogenic tumours mirrors the normal process of tooth development in important ways — some tumours even produce hard dental tissues (enamel, dentine, cementum) as part of their growth, which is a defining histological feature used in classification.

Why It Matters (Clinical + Exam Context)

Odontogenic tumours are a high-yield topic for dental board examinations and have direct clinical relevance because several of them are locally aggressive and associated with significant morbidity if inadequately treated.

Clinical Relevance

• Ameloblastoma and recurrence: The single most important clinical fact about ameloblastoma is its propensity to recur after conservative surgical treatment. Curettage alone has a reported recurrence rate of 50–90%. This drives the treatment strategy toward wide resection with adequate bony margins and long-term surveillance.
• Odontomas and impacted teeth: Compound and complex odontomas are frequently identified as the cause of tooth impaction, particularly of the maxillary canine or anterior teeth. When discovered, concurrent assessment for impacted teeth — and planning for exposure and orthodontic traction — is often required.
• Radiographic clues to diagnosis: The radiographic appearance of odontogenic tumours provides important diagnostic clues. A multilocular “soap-bubble” or “honeycomb” pattern in the posterior mandible in a young-to-middle-aged adult should raise the differential of ameloblastoma, odontogenic myxoma, or central giant cell granuloma. A well-defined unilocular radiolucency around the crown of an unerupted canine in a young female is classic for AOT.
• Malignant transformation: Although rare, benign odontogenic tumours — particularly long-standing dentigerous cysts, ameloblastomas, and calcifying epithelial odontogenic tumours — can undergo malignant transformation. Any recurrence after adequate treatment, or any rapidly growing, painful, or ulcerated component of a previously diagnosed benign lesion, must be re-biopsied urgently.

WHO Classification (2017)

The 2017 WHO Classification of Head and Neck Tumours reorganised odontogenic tumours into three major groups based on tissue of origin, simplifying previous classifications and aligning them with current molecular and biological understanding:

Benign Epithelial Odontogenic Tumors

Ameloblastoma

Ameloblastoma is the most clinically significant benign odontogenic tumour. It arises from odontogenic epithelium and mimics the histological appearance of the developing enamel organ without producing enamel. It is most common in the posterior mandible (third molar/ramus region), occurring predominantly in the third to fifth decades of life with roughly equal sex distribution.

Four subtypes are recognised in the 2017 WHO classification:

• Conventional ameloblastoma: The classic intraosseous variant; locally aggressive with a high recurrence rate; requires resection with 1–1.5 cm bony margins. Histological patterns include follicular (most common), plexiform, acanthomatous, granular cell, and desmoplastic subtypes.
• Unicystic ameloblastoma (UAM): A clinically distinct variant presenting as a unilocular cystic lesion, often associated with an unerupted mandibular third molar. UAM occurs in a younger age group and has a better prognosis; treatment varies from enucleation (luminal/intraluminal) to resection (mural subtype) depending on histological extent.
• Peripheral (extraosseous) ameloblastoma: Arises in the gingival soft tissue overlying the tooth-bearing areas. Does not invade bone. Treated by local excision; low recurrence rate.
• Metastasising ameloblastoma: A rare variant that, despite benign histological appearance, metastasises (most often to the lungs). Diagnosis is retrospective — made when a histologically benign ameloblastoma is found to have metastasised.

The radiographic appearance of conventional ameloblastoma is typically a well-defined, multilocular (“soap-bubble” or “honeycomb”) radiolucency causing significant jaw expansion, cortical thinning, and root resorption of adjacent teeth. The BRAF V600E mutation is identified in approximately 65% of conventional ameloblastomas and is under investigation as a therapeutic target.

Adenomatoid Odontogenic Tumour (AOT)

The AOT is a benign, encapsulated odontogenic tumour with a very characteristic clinical profile that makes it easily recognisable:

• The “2/3” tumour: Two-thirds of cases occur in females, two-thirds occur in the anterior maxilla, and two-thirds are associated with an unerupted tooth (the maxillary canine is most frequently involved).
• Patients are typically adolescents or young adults (10–19 years is the peak range).
• Radiographically it appears as a well-defined, unilocular radiolucency that extends beyond the CEJ of an impacted tooth (distinguishing it from a dentigerous cyst, which attaches at the CEJ). Small discrete calcifications (“snowflake” calcifications) within the lesion are a characteristic feature on CBCT or CT.
• Histologically it contains duct-like structures (adenomatoid formations) of columnar epithelial cells, amyloid-like material, and small calcifications. The tumour is encapsulated and separates easily from the jaw bone.
• Treatment is conservative enucleation; recurrence is extremely rare.

Calcifying Epithelial Odontogenic Tumour (CEOT / Pindborg Tumour)

The CEOT is a locally invasive odontogenic epithelial tumour named after its discoverer, Jens Pindborg. It is characterised histologically by sheets of polyhedral epithelial cells with prominent intercellular bridges, eosinophilic homogeneous material (amyloid-like), and concentric “Liesegang ring” calcifications (also called Liesegangsche Ringe). The classic radiographic appearance is a mixed radiolucent-radiopaque lesion with “driven snow” calcifications in the posterior mandible. Treatment is resection with clear margins, as it is more aggressive than many other odontogenic tumours.

Benign Mixed Odontogenic Tumors

Odontoma

The odontoma is the most common odontogenic tumour overall and represents a hamartoma — a disorganised proliferation of normal tooth-forming tissues — rather than a true neoplasm. Two morphological types exist:

• Compound odontoma: Multiple small tooth-like structures (denticles) in an organised arrangement resembling miniature teeth. Occurs most often in the anterior maxilla. May be associated with supernumerary teeth or impaction of adjacent permanent teeth.
• Complex odontoma: A disorganised mass of calcified dental tissues (enamel, dentine, cementum, pulp tissue) without any tooth-like organisation. Occurs most often in the posterior mandible. Appears as a dense, opaque mass on radiograph.

Both types present as well-defined, mixed radiolucent-radiopaque lesions in close association with an unerupted tooth. They are treated by simple enucleation; recurrence does not occur because they are not true neoplasms.

Odontogenic Myxoma (Myxofibroma)

The odontogenic myxoma is a benign but locally aggressive intraosseous tumour derived from the ectomesenchyme of the tooth germ (most likely the dental papilla or follicle). It is composed of stellate and spindle cells embedded in an abundant myxoid (mucoid) extracellular matrix with few collagen fibres. The lesion is not encapsulated and infiltrates the medullary spaces of bone, making complete removal difficult. Radiographically it produces a multilocular “soap-bubble,” “honeycomb,” or “tennis racket” (straight-walled, right-angle dividing septa) pattern. It most commonly occurs in the tooth-bearing areas of the mandible in young-to-middle-aged adults. Treatment is resection with bony margins because of the infiltrative nature and high recurrence rate (approximately 25%) after conservative surgery.

Cementoblastoma

The cementoblastoma is the only true neoplasm of cementum. It is characterised by the formation of cementum-like hard tissue in a mass fused to the root of a vital tooth — most commonly the mandibular first molar. The patient typically presents with pain and swelling. Radiographically it appears as a well-defined, densely opaque (cementum-like) mass surrounded by a thin radiolucent rim, fused to the root apex and causing root resorption. Treatment requires extraction of the involved tooth together with the attached tumour; recurrence is rare with complete removal.

Malignant Odontogenic Tumors

Malignant odontogenic tumours are rare and represent either de novo malignant transformation of odontogenic epithelium/ectomesenchyme, or malignant change within a pre-existing benign odontogenic lesion.

Clinical Considerations

Managing odontogenic tumours demands an individualised approach based on the specific tumour type, its biological behaviour, and patient factors:

• Multilocular vs. unilocular appearance: A multilocular radiolucency in the posterior mandible in a middle-aged adult has a broad differential: ameloblastoma, odontogenic myxoma, central giant cell granuloma, OKC, aneurysmal bone cyst, and central haemangioma. Biopsy is essential before surgical planning because treatment intensity differs dramatically between these entities.
• Surgical margins for ameloblastoma: The mandible is resected en bloc with at least 1 cm of macroscopically normal bone beyond the radiographic margin. Continuity resections are followed by reconstruction (free fibula flap is the gold standard for mandibular reconstruction). Frozen section assessment of the margin bone is performed intraoperatively.
• Conservative management of UAM: Unicystic ameloblastoma in a young patient may be managed by enucleation plus Carnoy’s solution or peripheral ostectomy, with close radiographic follow-up, provided histological review confirms a purely luminal or intraluminal pattern without mural invasion.
• Dental rehabilitation: Major jaw resection for odontogenic tumours requires long-term dental rehabilitation planning. Osseointegrated implants placed within the free flap or residual jaw are often the best prosthetic solution but require careful pre-surgical team planning.
• Surveillance: All odontogenic tumours require long-term radiographic follow-up. For ameloblastoma, annual panoramic radiographs for a minimum of 10 years are recommended given the propensity for late recurrence.

Common Mistakes & Misconceptions

• Misconception: “Odontoma is the most clinically significant odontogenic tumour because it is the most common.”
  Correction: Odontoma is the most common odontogenic tumour but it is a hamartoma with minimal clinical consequences — it is cured by simple excision and does not recur. Ameloblastoma is far less common but is the most clinically significant because of its aggressive behaviour and high recurrence rate after conservative treatment.
• Misconception: “Ameloblastoma is a malignant tumour.”
  Correction: Conventional ameloblastoma is benign histologically — it does not metastasise (with the exception of the rare metastasising variant). Its clinical aggressiveness relates to local invasion and bone destruction, not to malignant transformation. A separate diagnosis — ameloblastic carcinoma — is applied when cytological malignancy is present.
• Misconception: “AOT is always associated with the maxillary canine.”
  Correction: While the maxillary canine is the most commonly involved tooth in AOT, approximately one-third of cases are not associated with an unerupted tooth (non-follicular variant). The rule of “2/3” helps remember the most common scenario but does not apply to all cases.
• Misconception: “Cementoblastoma causes resorption of the tooth root.”
  Correction: Cementoblastoma does not simply resorb the root — it fuses to it. The cementum-like material of the tumour becomes continuous with the tooth root. The root is “incorporated” into the tumour mass, not destroyed separately, which is why extraction of the involved tooth and tumour must be performed as one unit.
• Misconception: “A multilocular jaw radiolucency is pathognomonic of ameloblastoma.”
  Correction: Multiple lesions can produce a multilocular jaw radiolucency: ameloblastoma, OKC, odontogenic myxoma, central giant cell granuloma, aneurysmal bone cyst, and central haemangioma. Histopathological examination is always required for a definitive diagnosis.

Related Topics

Odontogenic tumours share clinical, radiographic, and sometimes histological overlap with odontogenic cysts and non-odontogenic jaw lesions.

References & Sources

1. El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (Eds.). (2017). WHO Classification of Head and Neck Tumours, 4th ed. IARC Press.
2. Neville BW, Damm DD, Allen CM, Chi AC. (2016). Oral and Maxillofacial Pathology, 4th ed. Elsevier.
3. Regezi JA, Sciubba JJ, Jordan RCK. (2017). Oral Pathology: Clinical Pathologic Correlations, 7th ed. Elsevier.
4. Odell EW (Ed.). (2017). Cawson’s Essentials of Oral Pathology and Oral Medicine, 9th ed. Elsevier.
5. Brown NA, Rolland D, McHugh JB, et al. (2014). Activating FGFR2-RAS-BRAF mutations in ameloblastoma. Clinical Cancer Research, 20(21), 5517–5526.

Summary

Odontogenic tumours are a fascinating and clinically important group of jaw lesions that arise from the unique epithelial-mesenchymal interactions of tooth development. From the common and benign odontoma to the locally aggressive ameloblastoma and the rare but serious malignant odontogenic carcinomas, this group demands systematic classification, careful radiographic evaluation, and definitive histopathological diagnosis. The single most important clinical principle is that recurrence after conservative treatment of conventional ameloblastoma is expected, not exceptional, which makes wide surgical resection the standard of care despite its morbidity.

About the Author

Dr. Andries Smith

Founder, Dental Panda

Dr. Andries Smith founded Dental Panda in 2020. As an immigrant to the United States, he had to take the INBDE exam, even though he was practicing dentistry for over 10 years. This revealed an opportunity. Andries noticed that INBDE prep course companies were putting profit over students. With his expertise and experience in dentistry, he created free dental wiki resources for students and the general public to have access to.